Nymox Pharmaceutical Corporation logo

Nymox Pharmaceutical (NYMX) stock

NYMX · Nymox Pharmaceutical Corporation · NASDAQ

Website

What is the latest news on NYMX stock?

SECago
SEC Form 6-K filed by Nymox Pharmaceutical Corporation

6-K - NYMOX PHARMACEUTICAL CORP (0001018735) (Filer)

All NYMX news

Latest news

25 items

Nymox Pharmaceutical Corporation (NYMX) is a Biotechnology: In Vitro & In Vivo Diagnostic Substances company listed on NASDAQ. There were no new wire items for NYMX in the last 30 days. The most recent was published Nov 15, 2023.

Nymox Pharmaceutical Corporation, a biopharmaceutical company, engages in the research and development of drugs for the aging population in Canada, the United States, Europe, and internationally. Its lead drug candidate is Fexapotide Triflutate (NX-1207), which has completed Phase III clinical trials for the treatment of benign prostatic hyperplasia, and Phase II clinical trials for low grade localized prostate cancer, as well as is in preclinical studies for hepatocellular carcinoma. The company also develops and markets NicAlert and TobacAlert test strips that use urine or saliva to detect use of tobacco products. In addition, it offers AlzheimAlert, a proprietary urine assay that aids physicians in the diagnosis of Alzheimer's disease. The company was founded in 1989 and is headquartered in Nassau, The Bahamas.

NYMX FAQ

5 questions
  • What does Nymox Pharmaceutical Corporation do?
    Nymox Pharmaceutical Corporation, a biopharmaceutical company, engages in the research and development of drugs for the aging population in Canada, the United States, Europe, and internationally. Its lead drug candidate is Fexapotide Triflutate (NX-1207), which has completed Phase III clinical trials for the treatment of benign prostatic hyperplasia, and Phase II clinical trials for low grade localized prostate cancer, as well as is in preclinical studies for hepatocellular carcinoma. The company also develops and markets NicAlert and TobacAlert test strips that use urine or saliva to detect...
  • Where does NYMX stock trade?
    Nymox Pharmaceutical Corporation (NYMX) is listed on NASDAQ.
  • What sector and industry is NYMX in?
    Nymox Pharmaceutical Corporation operates in the Health Care sector, Biotechnology: In Vitro & In Vivo Diagnostic Substances industry.
  • What companies are similar to NYMX?
    Notable peers in the same industry include CLDX (Celldex Therapeutics Inc.), LNTH (Lantheus Holdings Inc.), NTLA (Intellia Therapeutics Inc.), ACHV (Achieve Life Sciences Inc.), ORKA (Oruka Therapeutics Inc.). Compare NYMX side-by-side with any of them on Quantisnow.
  • How can I track NYMX on Quantisnow?
    Quantisnow aggregates Nymox Pharmaceutical Corporation's SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow NYMX to receive live email and push alerts on every new disclosure.

Is something on this page wrong, or out of date? Request a change